Suppr超能文献

克隆的大鼠多巴胺 D2 受体与腺苷酸环化酶抑制及催乳素分泌的偶联。

Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.

作者信息

Albert P R, Neve K A, Bunzow J R, Civelli O

机构信息

Vollum Institute for Advanced Biomedical Research, Oregon Health Science University, Portland.

出版信息

J Biol Chem. 1990 Feb 5;265(4):2098-104.

PMID:1688845
Abstract

We have previously described a cDNA which encodes a binding site with the pharmacology of the D2-dopamine receptor (Bunzow, J. R., VanTol, H. H. M., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C., Neve, K. A., and Civelli, O. (1988) Nature 336, 783-787). We demonstrate here that this protein is a functional receptor, i.e. it couples to G-proteins to inhibit cAMP generation and hormone secretion. The cDNA was expressed in GH4C1 cells, a rat somatomammotrophic cell strain which lacks dopamine receptors. Stable transfectants were isolated and one clone, GH4ZR7, which had the highest levels of D2-dopamine receptor mRNA on Northern blot, was studied in detail. Binding of D2-dopamine antagonist [3H]spiperone to membranes isolated from GH4ZR7 cells was saturable, with KD = 96 pM, and Bmax = 2300 fmol/mg protein. Addition of GTP/NaCl increased the IC50 value for dopamine competition for [3H]spiperone binding by 2-fold, indicating that the D2-dopamine receptor interacts with one or more G-proteins. To assess the function of the dopamine-binding site, acute biological actions of dopamine were characterized in GH4ZR7 cells. Dopamine, at concentrations found in vivo, decreased resting intra- and extracellular cAMP levels (EC50 = 8 +/- 2 nM) by 50-70% and blocked completely vasoactive intestinal peptide (VIP) induced enhancement of cAMP levels (EC50 = 6 +/- 1 nM). Antagonism of dopamine-induced inhibition of VIP-enhanced cAMP levels by spiperone, (+)-butaclamol, (-)-sulpiride, and SCH23390 occurred at concentrations expected from KI values for these antagonists at the D2-receptor and was stereoselective. Dopamine (as well as several D2-selective agonists) inhibited forskolin-stimulated adenylate cyclase activity by 45 +/- 6%, with EC50 of 500-800 nM in GH4ZR7 membranes. Dopaminergic inhibition of cellular cAMP levels and of adenylyl cyclase activity in membrane preparations was abolished by pretreatment with pertussis toxin (50 ng/ml, 16 h). Dopamine (200 nM) abolished VIP- and thyrotropin-releasing hormone-induced acute prolactin release. These data show conclusively that the cDNA clone encodes a functional dopamine-D2 receptor which couples to G-proteins to inhibit adenylyl cyclase and both cAMP-dependent and cAMP-independent hormone secretion.

摘要

我们之前描述过一种cDNA,它编码一个具有D2 - 多巴胺受体药理学特性的结合位点(Bunzow, J. R., VanTol, H. H. M., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C., Neve, K. A., and Civelli, O. (1988) Nature 336, 783 - 787)。我们在此证明该蛋白是一种功能性受体,即它与G蛋白偶联以抑制cAMP生成和激素分泌。该cDNA在GH4C1细胞中表达,GH4C1是一种缺乏多巴胺受体的大鼠生长激素 - 催乳素细胞株。分离出稳定转染子,对其中一个在Northern印迹上D2 - 多巴胺受体mRNA水平最高的克隆GH4ZR7进行了详细研究。D2 - 多巴胺拮抗剂[3H]螺哌隆与从GH4ZR7细胞分离的膜的结合是可饱和的,KD = 96 pM,Bmax = 2300 fmol/mg蛋白。添加GTP/NaCl使多巴胺竞争[3H]螺哌隆结合的IC50值增加2倍,表明D2 - 多巴胺受体与一种或多种G蛋白相互作用。为评估多巴胺结合位点的功能,在GH4ZR7细胞中对多巴胺的急性生物学作用进行了表征。体内浓度的多巴胺使静息的细胞内和细胞外cAMP水平(EC50 = 8 +/- 2 nM)降低50 - 70%,并完全阻断血管活性肠肽(VIP)诱导的cAMP水平升高(EC50 = 6 +/- 1 nM)。螺哌隆、(+)-布他拉莫、(-)-舒必利和SCH23390对多巴胺诱导的VIP增强的cAMP水平抑制作用的拮抗作用发生在这些拮抗剂在D2受体的KI值所预期的浓度,并且具有立体选择性。多巴胺(以及几种D2选择性激动剂)在GH4ZR7膜中使福司可林刺激的腺苷酸环化酶活性抑制45 +/- 6%,EC50为500 - 800 nM。用百日咳毒素(50 ng/ml,16小时)预处理可消除多巴胺能对细胞cAMP水平和膜制剂中腺苷酸环化酶活性的抑制作用。多巴胺(200 nM)消除了VIP和促甲状腺激素释放激素诱导的急性催乳素释放。这些数据确凿地表明,该cDNA克隆编码一种功能性多巴胺 - D2受体,它与G蛋白偶联以抑制腺苷酸环化酶以及cAMP依赖性和非cAMP依赖性激素分泌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验